Nova Mentis Life Science Corp.: Nova Mentis Granted Health Canada Section 56 Exemption to Begin Psilocybin Clinical Trial
Vancouver, British Columbia--(Newsfile Corp. - February 14, 2023) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global